{"pmid":32252845,"title":"Adaptation of the National Plan for the Prevention and Fight Against Pandemic Influenza to the 2020 COVID-19 epidemic in France.","text":["Adaptation of the National Plan for the Prevention and Fight Against Pandemic Influenza to the 2020 COVID-19 epidemic in France.","On Tuesday 17th March 2020 at noon, France became the third European country to impose a nationwide containment policy in the fight against epidemic COVID-19 viral infection. Announcing that the country was at \"war\", President Macron called upon all to play a role in mitigating against further development of contagion. This extreme measure never seen before during peace time was the result of adapting not only the French Pandemic Influenza Plan (PIP) being applied to the national context but also real-time clinical, epidemiological and scientific information about the evolution of COVID-19 infection in the country. The situation was further complicated by local municipal elections and political agendas by populist opinions. Despite mass communication about the importance of individual behavioral attitudes to counter disease propagation, few heeded government advice. Consequently, the situation rapidly deteriorated with increasing number of cases that started to overwhelm health services. As a result, decisive and immediate action was taken by the State for the national public health interest. This report from the field details the timely events which contributed to this extreme policy decision taken by France. A policy decision which other western democracies have since applied as the pandemic disseminated across the globe.","Disaster Med Public Health Prep","Ghanchi, A","32252845"],"abstract":["On Tuesday 17th March 2020 at noon, France became the third European country to impose a nationwide containment policy in the fight against epidemic COVID-19 viral infection. Announcing that the country was at \"war\", President Macron called upon all to play a role in mitigating against further development of contagion. This extreme measure never seen before during peace time was the result of adapting not only the French Pandemic Influenza Plan (PIP) being applied to the national context but also real-time clinical, epidemiological and scientific information about the evolution of COVID-19 infection in the country. The situation was further complicated by local municipal elections and political agendas by populist opinions. Despite mass communication about the importance of individual behavioral attitudes to counter disease propagation, few heeded government advice. Consequently, the situation rapidly deteriorated with increasing number of cases that started to overwhelm health services. As a result, decisive and immediate action was taken by the State for the national public health interest. This report from the field details the timely events which contributed to this extreme policy decision taken by France. A policy decision which other western democracies have since applied as the pandemic disseminated across the globe."],"journal":"Disaster Med Public Health Prep","authors":["Ghanchi, A"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32252845","week":"202015|Apr 06 - Apr 12","doi":"10.1017/dmp.2020.82","keywords":["COVID-19","Emergency planning","France","Pandemic Influenza Plan","Public health emergency of international concern","health crisis management"],"source":"PubMed","locations":["European","French","France"],"countries":["France"],"countries_codes":["FRA|France"],"topics":["Prevention"],"weight":1,"_version_":1663450393535840257,"score":7.9164424,"similar":[{"pmid":32162604,"title":"How Is the World Responding to the 2019 Coronavirus Disease Compared with the 2014 West African Ebola Epidemic? The Importance of China as a Player in the Global Economy.","text":["How Is the World Responding to the 2019 Coronavirus Disease Compared with the 2014 West African Ebola Epidemic? The Importance of China as a Player in the Global Economy.","This article describes similarities and differences in the response of governments and the international community to the current 2019 coronavirus disease (COVID-19) and the 2014 West African Ebola epidemic. It expresses the opinion that the speed and scale of the response to the 2019 COVID-19 are affected by the important role that China plays in the global economy. By contrast, insufficient and less timely action was initially undertaken in West African countries during the 2014 Ebola epidemic. It concludes by stating why preparedness for and response to all disease outbreaks, also in countries of lower economic importance, should become a priority in the global health agenda.","Am J Trop Med Hyg","Maffioli, Elisa M","32162604"],"abstract":["This article describes similarities and differences in the response of governments and the international community to the current 2019 coronavirus disease (COVID-19) and the 2014 West African Ebola epidemic. It expresses the opinion that the speed and scale of the response to the 2019 COVID-19 are affected by the important role that China plays in the global economy. By contrast, insufficient and less timely action was initially undertaken in West African countries during the 2014 Ebola epidemic. It concludes by stating why preparedness for and response to all disease outbreaks, also in countries of lower economic importance, should become a priority in the global health agenda."],"journal":"Am J Trop Med Hyg","authors":["Maffioli, Elisa M"],"date":"2020-03-13T11:00:00Z","year":2020,"_id":"32162604","week":"202011|Mar 09 - Mar 15","doi":"10.4269/ajtmh.20-0135","source":"PubMed","locations":["West African","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1663352134035308545,"score":217.8896},{"pmid":32267243,"title":"Health risks and potential remedies during prolonged lockdowns for coronavirus disease 2019 (COVID-19).","text":["Health risks and potential remedies during prolonged lockdowns for coronavirus disease 2019 (COVID-19).","As coronavirus disease 2019 (COVID-19) pandemic continues, an increasing number of countries and territories are adopting restrictive measures based on physical (\"social\") distancing, aimed at preventing human-to-human transmission and thereby limiting virus propagation. Nationwide lockdowns, encompassing mass quarantine under stay-at-home ordinances, have already been proven effective to contain the COVID-19 outbreak in some countries. Nevertheless, a prolonged homestay may also be associated with potential side effects, which may jeopardize people's health and thus must be recognized and mitigated in a way without violating local ordinances. Some of the most important undesirable consequences of prolonged homestay such as physical inactivity, weight gain, behavioral addiction disorders, insufficient sunlight exposure and social isolation will be critically addressed in this article, which also aims to provide some tentative recommendations for the alleviation of side effects.","Diagnosis (Berl)","Lippi, Giuseppe","Henry, Brandon M","Bovo, Chiara","Sanchis-Gomar, Fabian","32267243"],"abstract":["As coronavirus disease 2019 (COVID-19) pandemic continues, an increasing number of countries and territories are adopting restrictive measures based on physical (\"social\") distancing, aimed at preventing human-to-human transmission and thereby limiting virus propagation. Nationwide lockdowns, encompassing mass quarantine under stay-at-home ordinances, have already been proven effective to contain the COVID-19 outbreak in some countries. Nevertheless, a prolonged homestay may also be associated with potential side effects, which may jeopardize people's health and thus must be recognized and mitigated in a way without violating local ordinances. Some of the most important undesirable consequences of prolonged homestay such as physical inactivity, weight gain, behavioral addiction disorders, insufficient sunlight exposure and social isolation will be critically addressed in this article, which also aims to provide some tentative recommendations for the alleviation of side effects."],"journal":"Diagnosis (Berl)","authors":["Lippi, Giuseppe","Henry, Brandon M","Bovo, Chiara","Sanchis-Gomar, Fabian"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32267243","week":"202015|Apr 06 - Apr 12","doi":"10.1515/dx-2020-0041","keywords":["COVID-19","coronavirus","epidemics","health","outbreak"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1663609715755581441,"score":200.7575},{"pmid":32238336,"title":"Global Telemedicine Implementation and Integration Within Health Systems to Fight the COVID-19 Pandemic: A Call to Action.","text":["Global Telemedicine Implementation and Integration Within Health Systems to Fight the COVID-19 Pandemic: A Call to Action.","On March 11, 2020, the World Health Organization declared the coronavirus disease 2019 (COVID-19) outbreak as a pandemic, with over 720,000 cases reported in more than 203 countries as of 31 March. The response strategy included early diagnosis, patient isolation, symptomatic monitoring of contacts as well as suspected and confirmed cases, and public health quarantine. In this context, telemedicine, particularly video consultations, has been promoted and scaled up to reduce the risk of transmission, especially in the United Kingdom and the United States of America. Based on a literature review, the first conceptual framework for telemedicine implementation during outbreaks was published in 2015. An updated framework for telemedicine in the COVID-19 pandemic has been defined. This framework could be applied at a large scale to improve the national public health response. Most countries, however, lack a regulatory framework to authorize, integrate, and reimburse telemedicine services, including in emergency and outbreak situations. In this context, Italy does not include telemedicine in the essential levels of care granted to all citizens within the National Health Service, while France authorized, reimbursed, and actively promoted the use of telemedicine. Several challenges remain for the global use and integration of telemedicine into the public health response to COVID-19 and future outbreaks. All stakeholders are encouraged to address the challenges and collaborate to promote the safe and evidence-based use of telemedicine during the current pandemic and future outbreaks. For countries without integrated telemedicine in their national health care system, the COVID-19 pandemic is a call to adopt the necessary regulatory frameworks for supporting wide adoption of telemedicine.","JMIR Public Health Surveill","Ohannessian, Robin","Duong, Tu Anh","Odone, Anna","32238336"],"abstract":["On March 11, 2020, the World Health Organization declared the coronavirus disease 2019 (COVID-19) outbreak as a pandemic, with over 720,000 cases reported in more than 203 countries as of 31 March. The response strategy included early diagnosis, patient isolation, symptomatic monitoring of contacts as well as suspected and confirmed cases, and public health quarantine. In this context, telemedicine, particularly video consultations, has been promoted and scaled up to reduce the risk of transmission, especially in the United Kingdom and the United States of America. Based on a literature review, the first conceptual framework for telemedicine implementation during outbreaks was published in 2015. An updated framework for telemedicine in the COVID-19 pandemic has been defined. This framework could be applied at a large scale to improve the national public health response. Most countries, however, lack a regulatory framework to authorize, integrate, and reimburse telemedicine services, including in emergency and outbreak situations. In this context, Italy does not include telemedicine in the essential levels of care granted to all citizens within the National Health Service, while France authorized, reimbursed, and actively promoted the use of telemedicine. Several challenges remain for the global use and integration of telemedicine into the public health response to COVID-19 and future outbreaks. All stakeholders are encouraged to address the challenges and collaborate to promote the safe and evidence-based use of telemedicine during the current pandemic and future outbreaks. For countries without integrated telemedicine in their national health care system, the COVID-19 pandemic is a call to adopt the necessary regulatory frameworks for supporting wide adoption of telemedicine."],"journal":"JMIR Public Health Surveill","authors":["Ohannessian, Robin","Duong, Tu Anh","Odone, Anna"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32238336","week":"202014|Mar 30 - Apr 05","doi":"10.2196/18810","keywords":["*COVID-19","*SARS-CoV-2","*coronavirus","*digital health","*digital medicine","*outbreak","*pandemic","*public health","*surveillance","*telehealth","*telemedicine"],"source":"PubMed","locations":["United Kingdom","Italy","France"],"countries":["Italy","United Kingdom","France"],"countries_codes":["ITA|Italy","GBR|United Kingdom","FRA|France"],"topics":["Prevention"],"weight":1,"_version_":1663352135576715264,"score":199.11092},{"pmid":32265115,"title":"COVID-19 in Colombia endpoints. Are we different, like Europe?","text":["COVID-19 in Colombia endpoints. Are we different, like Europe?","The infection by the new coronavirus (SARS-CoV-2) has taken the dimension of a pandemic, affecting more than 160 countries in a few weeks. In Colombia, despite the implementation of the rules established by the national government, exists an elevate concern both for mortality and for the limited capacity of the health system to respond effectively to the needs of patients infected. For Colombia, assuming a case fatality rate among people infected with SARS-CoV-2 of 0.6% (average data from the information reported for Latin American countries for March 18) (Table 1), the number of deaths, in one or two weeks, could be 16 and 243, respectively. These estimates differ markedly from those documented in countries such as Spain and Italy, in which COVID-19 case fatality rates exceed 8% (case of Italy) and from the percentage of patients who have required intensive care, which has ranged from 9% to 11% of patients in Mediterranean European countries. These differences could be explained due to: a) the percentage of the population at risk (individuals older than 60 years); b) a higher epidemiological exposure to viral respiratory infections associated with more frequent exposure to them, due to geographic and climatic conditions; c) less spread of the virus by location in the tropical zone; and d) earlier preventive measures to contain the spread of SARS-CoV-2 infection. Therefore, it is possible to establish that the situation in this country will be different from in European Mediterranean and that Colombia could have different endpoints from Spain and Italy.","Res Social Adm Pharm","Amariles, Pedro","Granados, Johan","Ceballos, Mauricio","Montoya, Carlos Julio","32265115"],"abstract":["The infection by the new coronavirus (SARS-CoV-2) has taken the dimension of a pandemic, affecting more than 160 countries in a few weeks. In Colombia, despite the implementation of the rules established by the national government, exists an elevate concern both for mortality and for the limited capacity of the health system to respond effectively to the needs of patients infected. For Colombia, assuming a case fatality rate among people infected with SARS-CoV-2 of 0.6% (average data from the information reported for Latin American countries for March 18) (Table 1), the number of deaths, in one or two weeks, could be 16 and 243, respectively. These estimates differ markedly from those documented in countries such as Spain and Italy, in which COVID-19 case fatality rates exceed 8% (case of Italy) and from the percentage of patients who have required intensive care, which has ranged from 9% to 11% of patients in Mediterranean European countries. These differences could be explained due to: a) the percentage of the population at risk (individuals older than 60 years); b) a higher epidemiological exposure to viral respiratory infections associated with more frequent exposure to them, due to geographic and climatic conditions; c) less spread of the virus by location in the tropical zone; and d) earlier preventive measures to contain the spread of SARS-CoV-2 infection. Therefore, it is possible to establish that the situation in this country will be different from in European Mediterranean and that Colombia could have different endpoints from Spain and Italy."],"journal":"Res Social Adm Pharm","authors":["Amariles, Pedro","Granados, Johan","Ceballos, Mauricio","Montoya, Carlos Julio"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32265115","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.sapharm.2020.03.013","source":"PubMed","locations":["Latin American","Spain","Italy","Colombia"],"countries":["Italy","Spain","Colombia"],"countries_codes":["ITA|Italy","ESP|Spain","COL|Colombia"],"topics":["Epidemic Forecasting","Prevention"],"weight":1,"_version_":1663609715781795842,"score":188.30238},{"pmid":32271861,"title":"Awareness, Attitudes, and Actions Related to COVID-19 Among Adults With Chronic Conditions at the Onset of the U.S. Outbreak: A Cross-sectional Survey.","text":["Awareness, Attitudes, and Actions Related to COVID-19 Among Adults With Chronic Conditions at the Onset of the U.S. Outbreak: A Cross-sectional Survey.","Background: The evolving outbreak of coronavirus disease 2019 (COVID-19) is requiring social distancing and other measures to protect public health. However, messaging has been inconsistent and unclear. Objective: To determine COVID-19 awareness, knowledge, attitudes, and related behaviors among U.S. adults who are more vulnerable to complications of infection because of age and comorbid conditions. Design: Cross-sectional survey linked to 3 active clinical trials and 1 cohort study. Setting: 5 academic internal medicine practices and 2 federally qualified health centers. Patients: 630 adults aged 23 to 88 years living with 1 or more chronic conditions. Measurements: Self-reported knowledge, attitudes, and behaviors related to COVID-19. Results: A fourth (24.6%) of participants were \"very worried\" about getting the coronavirus. Nearly a third could not correctly identify symptoms (28.3%) or ways to prevent infection (30.2%). One in 4 adults (24.6%) believed that they were \"not at all likely\" to get the virus, and 21.9% reported that COVID-19 had little or no effect on their daily routine. One in 10 respondents was very confident that the federal government could prevent a nationwide outbreak. In multivariable analyses, participants who were black, were living below the poverty level, and had low health literacy were more likely to be less worried about COVID-19, to not believe that they would become infected, and to feel less prepared for an outbreak. Those with low health literacy had greater confidence in the federal government response. Limitation: Cross-sectional study of adults with underlying health conditions in 1 city during the initial week of the COVID-19 U.S. outbreak. Conclusion: Many adults with comorbid conditions lacked critical knowledge about COVID-19 and, despite concern, were not changing routines or plans. Noted disparities suggest that greater public health efforts may be needed to mobilize the most vulnerable communities. Primary Funding Source: National Institutes of Health.","Ann Intern Med","Wolf, Michael S","Serper, Marina","Opsasnick, Lauren","O'Conor, Rachel M","Curtis, Laura M","Benavente, Julia Yoshino","Wismer, Guisselle","Batio, Stephanie","Eifler, Morgan","Zheng, Pauline","Russell, Andrea","Arvanitis, Marina","Ladner, Daniela","Kwasny, Mary","Persell, Stephen D","Rowe, Theresa","Linder, Jeffrey A","Bailey, Stacy C","32271861"],"abstract":["Background: The evolving outbreak of coronavirus disease 2019 (COVID-19) is requiring social distancing and other measures to protect public health. However, messaging has been inconsistent and unclear. Objective: To determine COVID-19 awareness, knowledge, attitudes, and related behaviors among U.S. adults who are more vulnerable to complications of infection because of age and comorbid conditions. Design: Cross-sectional survey linked to 3 active clinical trials and 1 cohort study. Setting: 5 academic internal medicine practices and 2 federally qualified health centers. Patients: 630 adults aged 23 to 88 years living with 1 or more chronic conditions. Measurements: Self-reported knowledge, attitudes, and behaviors related to COVID-19. Results: A fourth (24.6%) of participants were \"very worried\" about getting the coronavirus. Nearly a third could not correctly identify symptoms (28.3%) or ways to prevent infection (30.2%). One in 4 adults (24.6%) believed that they were \"not at all likely\" to get the virus, and 21.9% reported that COVID-19 had little or no effect on their daily routine. One in 10 respondents was very confident that the federal government could prevent a nationwide outbreak. In multivariable analyses, participants who were black, were living below the poverty level, and had low health literacy were more likely to be less worried about COVID-19, to not believe that they would become infected, and to feel less prepared for an outbreak. Those with low health literacy had greater confidence in the federal government response. Limitation: Cross-sectional study of adults with underlying health conditions in 1 city during the initial week of the COVID-19 U.S. outbreak. Conclusion: Many adults with comorbid conditions lacked critical knowledge about COVID-19 and, despite concern, were not changing routines or plans. Noted disparities suggest that greater public health efforts may be needed to mobilize the most vulnerable communities. Primary Funding Source: National Institutes of Health."],"journal":"Ann Intern Med","authors":["Wolf, Michael S","Serper, Marina","Opsasnick, Lauren","O'Conor, Rachel M","Curtis, Laura M","Benavente, Julia Yoshino","Wismer, Guisselle","Batio, Stephanie","Eifler, Morgan","Zheng, Pauline","Russell, Andrea","Arvanitis, Marina","Ladner, Daniela","Kwasny, Mary","Persell, Stephen D","Rowe, Theresa","Linder, Jeffrey A","Bailey, Stacy C"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32271861","week":"202015|Apr 06 - Apr 12","doi":"10.7326/M20-1239","source":"PubMed","locations":["USA"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1663620083142885376,"score":179.16531}]}